News

AFFiRiS Announces Encouraging Long-term Data from a Series of First-in-Human Studies Using AFFITOPE® PD01A Targeting Oligomeric Alpha-synuclein in Early Parkinson’s Disease Patients

Leonid Sazanov elected member of EMBO

Hereditary bowel cancer: mesalazine attenuates tumour formation by 50%

Arsanis Reports Business Highlights and Financial Results for First Quarter 2018